Power Law company profile

Prometheus Biosciences

Biotech & Life Sciences · San Diego, United States · Founded 1995 · IPO 2021 Unicorn

Committed to the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune disease

Valuation

$8.87B

Market cap · 2026

Revenue

$6.8M

Latest reported FY

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026

Investors

10 investors on Prometheus Biosciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 10 investors entered at this stage

Cormorant Capital

Point72

Eventide Asset Management

RTW Investments

Perceptive Advisors

Irving Investors

Cedars-Sinai

Ascend Global Investments

Nestlé

Cowen Group

Prometheus Biosciences mafia

Startups founded by Prometheus Biosciences alumni

Former Prometheus Biosciences employees who went on to start their own companies. Sorted by Dealroom signal score.

Mirador TherapeuticsEst. 2024

MMMark McKennaUnited States

Signal score93

Shoreline BiosciencesEst. 2020

William SandbornUnited States

Signal score61

HilleVaxEst. 2021

David SocksUnited States

Signal score60

Alastin SkincareEst. 2015

Scott GlennUnited States

Signal score59

Book a demo to explore the full alumni network →

Global footprint

Where Prometheus Biosciences has talent and traffic

Workforce by country

🇺🇸 United States · San Diego HQ

Book a demo for the full country breakdown

Patent intelligence

$37M patent portfolio · 47 active families

Estimated portfolio value

$37M

0.41% of market cap · 55.1× smaller than top peer Ablynx ($2B)

47 active patent families

Where Prometheus Biosciences innovates Molecular biologyAutoimmune inflammatory bowel diseaseBowels diseasesAntiendomysial antibodiesUlcerative colitis

Where Prometheus Biosciences concentrates vs peers

Each axis is a top-10 topic across Prometheus Biosciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Prometheus Biosciences

An AI-synthesized read of the highest-engagement posts about Prometheus Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Prometheus Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles